Loading clinical trials...
Loading clinical trials...
DYSPORT™ for Injection AbobotulinumtoxinA Neurotoxin Clinical & Health Economics Outcomes Registry in Cervical Dystonia (ANCHOR-CD)
The purpose of the protocol is to determine typical patient response to Dysport in the treatment of adult cervical dystonia (CD).
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Arizona Dystonia Institute
Scottsdale, Arizona, United States
East Bay Physicians Medical Group
Berkeley, California, United States
Headache Center
Encinitas, California, United States
The Parkinson's & Movement Disorder Institute
Fountain Valley, California, United States
Neuro-Pain Medical Center
Fresno, California, United States
Coastal Neurological Medical Group, Inc.
La Jolla, California, United States
Valley Parkinson Clinic
Los Gatos, California, United States
Harvinder S. Birk
Redding, California, United States
Colorado Springs Neurological Associates
Colorado Springs, Colorado, United States
University of Colorado Denver
Denver, Colorado, United States
Start Date
April 1, 2011
Primary Completion Date
November 1, 2013
Completion Date
March 1, 2014
Last Updated
November 5, 2020
350
ACTUAL participants
Lead Sponsor
Ipsen
NCT06328114
NCT03938363
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT02689466